Balsalazide achieved symptomatic remission sooner than mesalamine for ulcerative colitis

Pruitt, R.; Hanson, J.; Safdi, M.; McDonald, John W.D.
May 2003
ACP Journal Club;May/Jun2003, Vol. 138 Issue 3, p71
Academic Journal
Summarizes a study that investigated whether treatment with balsalazide achieves higher symptomatic remission rates than mesalamine in patients with active, mild-to-moderate ulcerative colitis. Characterization of the patients; Main outcome measures; Results of the study.


Related Articles

  • DILATATION OF THE COLON, A SERIOUS COMPLICATION OF ULCERATIVE COLITIS. Korelitz, B.I.; Janowitz, H.D. // Annals of Internal Medicine;Jul60, Vol. 53 Issue 1, p153 

    Presents two representative cases of dilatation of the colon as a serious complication of ulcerative colitis. Survey of literature on the disorder; Details of the case reports.

  • "Ulcerative Appendicitis" Occurring as a Skip Lesion in Chronic Ulcerative Colitis. Cohen, Theodore; Pfeffer, Robert B.; Valensi, Quentin // American Journal of Gastroenterology;Aug1974, Vol. 62 Issue 2, p151 

    A 39-year old white female with a 19-year history of chronic ulcerative colitis was admitted to the hospital with fulminating disease and toxic megacolon requiring total colectomy. The appendicial changes were most unusual. The pathological changes were typical of those seen in ulcerative...

  • THE GRAVE PROGNOSIS OF ULCERATIVE COLITIS ENGRAFTED UPON ACUTE DIVERTICULITIS COLI. Collins, Donald C. // American Journal of Gastroenterology;Mar1961, Vol. 35 Issue 3, p222 

    1. Sixteen patients (1.41 per cent) were encountered in 1,140 consecutive examples of acute diverticulitis coli, that had an engraftment of acute ulcerative colitis upon their original colonic diverticular disease. 2. In comparing the two groups of individuals, the small aggregation of 16...

  • SURGICAL CURE OF ULCERATIVE COLITIS. Boehme, Earl J. // American Journal of Gastroenterology;Jul1960, Vol. 34 Issue 1, p74 

    Discusses the surgical treatments for ulcerative colitis. Reason for a fewer number of patients undergoing surgery for ulcerative colitis; Implication of steroid administration in ulcerative colitis with colonic bleeding; Regimen of treatment with ulcerative colitis patients during remission...

  • Surgical management of ulcerative colitis. Bennis, Malika; Tiret, Emmanuel // Langenbeck's Archives of Surgery;Jan2012, Vol. 397 Issue 1, p11 

    Introduction: Surgery is the only curative option in the treatment of ulcerative colitis. Despite advances in the medical management surgery is required in about a third of patients. Surgical management: In the acute setting surgery is indicated when medical treatment fails to improve an episode...

  • The Isolated Polyp in Ulcerative Colitis. Ruoff, Michael; Lindner, Arthur E. // American Journal of Gastroenterology;May1971, Vol. 55 Issue 5, p471 

    Describes the management of an ulcerative colitis patient by colotomy and polypectomy. Background on the patient; Result of the pathologic examination of the polyp; Projections observed from the mucosal surface in ulcerative colitis.

  • Colitis in the Elderly. Brandt, Lawrence J. // American Journal of Gastroenterology;Jun1992, Vol. 87 Issue 6, p691 

    Discusses the spectrum of colitis in the elderly. Causes of the disease; Problems in the diagnosis of the disorder; Features of an ulcerative colitis.

  • Polyamine Metabolism in Colonic Mucosa from Patients with Ulcerative Colitis. Obayashi, Makoto; Matsui-Yuasa, Isao; Matsumoto, Takayuki; Kitano, Atsuo; Kobayashi, Kenzo; Otani, Shuzo // American Journal of Gastroenterology;Jun1992, Vol. 87 Issue 6, p736 

    Polyamine metabolism in mucosa both from patients in the active or remission stage of ulcerative colitis (UC) and from healthy controls was studied. In the active stage of UC, mucosal spermidine concentration was higher than in remission or in the controls, but the activities of ornithine...

  • Once-daily formulation of mesalamine induces, maintains remission in patients with ulcerative colitis.  // Formulary;Jan2007, Vol. 42 Issue 1, p58 

    Information about several papers discussed at the American College of Gastroenterology Annual Scientific Meeting in Las Vegas, Nevada is presented. A once-daily formulation of mesalamine that relies on multimatrix (MMX) technology is effective agent in inducing and maintaining remission in...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics